• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hsa_circ_RNA_0011780通过靶向miR-544a降低FBXW7来抑制非小细胞肺癌的增殖和转移。

Hsa_circ_RNA_0011780 Represses the Proliferation and Metastasis of Non-Small Cell Lung Cancer by Decreasing FBXW7 via Targeting miR-544a.

作者信息

Liu Yong, Yang Chuanping, Cao Chengsong, Li Qing, Jin Xin, Shi Hanping

机构信息

Department of Oncology, Xuzhou Central Hospital, Xuzhou School of Clinical Medicine, Nanjing Medical University, Xuzhou 221000, People's Republic of China.

Department of Thoracic Surgery, Xuzhou Central Hospital, Xuzhou School of Clinical Medicine, Nanjing Medical University, Xuzhou 221000, People's Republic of China.

出版信息

Onco Targets Ther. 2020 Jan 23;13:745-755. doi: 10.2147/OTT.S236162. eCollection 2020.

DOI:10.2147/OTT.S236162
PMID:32158226
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6986254/
Abstract

PURPOSE

Circular RNA (circRNA) is involved in the development of various cancers. However, whether circRNA can inhibit the tumorigenesis of non-small cell lung cancer (NSCLC) is still unclear. We aimed to explore the epigenetic function of tumor-suppressive circRNA (hsa_circ_RNA_0011780) and its downstream regulatory factors in NSCLC.

PATIENTS AND METHODS

Quantitative polymerase chain reaction (qPCR) was used to evaluate hsa_circ_11780 expression in NSCLC tissues and cell lines. The impact of high hsa_circ_11780 expression on overall survival in patients with NSCLC was tested using the Log rank test. The association between decreased hsa_circ_11780 expression and clinicopathological features in patients with NSCLC was analyzed using the Chi-squared test. In vitro cell proliferation and apoptosis were assayed using the cell counting kit-8 (CCK-8) and flow cytometry, respectively. Mice xenograft models were used to determine the tumor promoting effects of hsa_circ_11780 on NSCLC in vivo. The underlying regulatory mechanism was predicted by bioinformatics and verified by a dual-luciferase reporter assay, RNA transfection, qPCR, and Western blotting. The correlation between miR-544a and hsa_circ_11780 expression was verified using Spearman correlation coefficient.

RESULTS

The expression of hsa_circ_11780 in NSCLC tissues and cell lines strongly declined. Low hsa_circ_11780 expression is more likely to present in patients with a large tumor size (>3cm), distant metastasis, and poor overall survival. hsa_circ_11780 overexpression strongly inhibited proliferation, migration, and invasion of NSCLC cells (H226 and A549) in vitro and inhibited tumor growth in vivo. Furthermore, hsa_circ_11780 repressed miR-544a function by competitively binding to the complementary sites of miR-544a. miR-544a released by the declining expression of hsa_circ_11780 reduced the protein concentration of F-Box and WD repeat domain containing 7 (FBXW7) in NSCLC cells.

CONCLUSION

FBXW7 expression mediated by the hsa_circ_11780/miR-544a axis is markedly associated with the proliferation, migration, and invasion of NSCLC, resulting in decreased survival. These findings suggest that this regulatory axis may serve as a novel therapeutic target in NSCLC.

摘要

目的

环状RNA(circRNA)参与多种癌症的发生发展。然而,circRNA是否能抑制非小细胞肺癌(NSCLC)的肿瘤发生仍不清楚。我们旨在探讨抑癌circRNA(hsa_circ_RNA_0011780)及其下游调控因子在NSCLC中的表观遗传功能。

患者与方法

采用定量聚合酶链反应(qPCR)评估hsa_circ_11780在NSCLC组织和细胞系中的表达。使用对数秩检验检测高hsa_circ_11780表达对NSCLC患者总生存期的影响。采用卡方检验分析hsa_circ_11780表达降低与NSCLC患者临床病理特征之间的相关性。分别使用细胞计数试剂盒-8(CCK-8)和流式细胞术检测体外细胞增殖和凋亡。利用小鼠异种移植模型确定hsa_circ_11780在体内对NSCLC的促肿瘤作用。通过生物信息学预测潜在的调控机制,并通过双荧光素酶报告基因检测、RNA转染、qPCR和蛋白质印迹法进行验证。使用Spearman相关系数验证miR-544a与hsa_circ_11780表达之间的相关性。

结果

hsa_circ_11780在NSCLC组织和细胞系中的表达显著下降。hsa_circ_11780低表达更易出现在肿瘤体积较大(>3cm)、远处转移且总生存期较差的患者中。hsa_circ_11780过表达在体外强烈抑制NSCLC细胞(H226和A549)的增殖、迁移和侵袭,并在体内抑制肿瘤生长。此外,hsa_circ_11780通过竞争性结合miR-544a的互补位点抑制miR-544a的功能。hsa_circ_11780表达下降释放的miR-544a降低了NSCLC细胞中含F-Box和WD重复结构域7(FBXW7)的蛋白浓度。

结论

hsa_circ_11780/miR-544a轴介导的FBXW7表达与NSCLC细胞的增殖、迁移和侵袭显著相关,导致生存期缩短。这些发现表明该调控轴可能成为NSCLC的一个新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffa/6986254/17486fc97138/OTT-13-745-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffa/6986254/3f725d5f29aa/OTT-13-745-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffa/6986254/9e8d69575158/OTT-13-745-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffa/6986254/6b10ef90a1f8/OTT-13-745-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffa/6986254/ed7326287d83/OTT-13-745-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffa/6986254/17486fc97138/OTT-13-745-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffa/6986254/3f725d5f29aa/OTT-13-745-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffa/6986254/9e8d69575158/OTT-13-745-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffa/6986254/6b10ef90a1f8/OTT-13-745-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffa/6986254/ed7326287d83/OTT-13-745-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffa/6986254/17486fc97138/OTT-13-745-g0005.jpg

相似文献

1
Hsa_circ_RNA_0011780 Represses the Proliferation and Metastasis of Non-Small Cell Lung Cancer by Decreasing FBXW7 via Targeting miR-544a.Hsa_circ_RNA_0011780通过靶向miR-544a降低FBXW7来抑制非小细胞肺癌的增殖和转移。
Onco Targets Ther. 2020 Jan 23;13:745-755. doi: 10.2147/OTT.S236162. eCollection 2020.
2
ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.ELF1 激活的长链非编码 RNA CASC2 通过 miR-18a/IRF-2 信号通路抑制非小细胞肺癌的顺铂耐药性。
Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3130-3142. doi: 10.26355/eurrev_202003_20680.
3
Deregulation of circRNA hsa_circ_0009109 promotes tumor growth and initiates autophagy by sponging miR-544a-3p in gastric cancer.环状RNA hsa_circ_0009109的失调通过在胃癌中吸附miR-544a-3p促进肿瘤生长并引发自噬。
Gastroenterol Rep (Oxf). 2024 Feb 28;12:goae008. doi: 10.1093/gastro/goae008. eCollection 2024.
4
HSA_CIRC_0004050 on proliferation and apoptosis of A549 cells through ERK/JNK signaling pathway.HSA_CIRC_0004050 通过 ERK/JNK 信号通路对 A549 细胞的增殖和凋亡的影响。
J Biol Regul Homeost Agents. 2020 Nov-Dec;34(6):2037-2047. doi: 10.23812/20-543-A.
5
Hsa_circ_0092887 targeting miR-490-5p/UBE2T promotes paclitaxel resistance in non-small cell lung cancer.Hsa_circ_0092887 通过靶向 miR-490-5p/UBE2T 促进非小细胞肺癌对紫杉醇的耐药性。
J Clin Lab Anal. 2023 Jan;37(1):e24781. doi: 10.1002/jcla.24781. Epub 2022 Dec 22.
6
circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.circ_0007385 作为竞争性内源性 RNA,与 miR-519d-3p 结合,抑制非小细胞肺癌细胞的恶性行为和顺铂耐药性。
Thorac Cancer. 2020 Aug;11(8):2196-2208. doi: 10.1111/1759-7714.13527. Epub 2020 Jun 29.
7
Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression.大豆异黄酮染料木黄酮抑制hsa_circ_0031250/miR-873-5p/FOXM1轴以抑制非小细胞肺癌进展。
IUBMB Life. 2021 Jan;73(1):92-107. doi: 10.1002/iub.2404. Epub 2020 Nov 7.
8
Downregulation of Hsa_circ_0000735 Inhibits the Proliferation, Migration, Invasion, and Glycolysis in Non-small-cell Lung Cancer by Targeting miR-940/BMPER Axis.Hsa_circ_0000735的下调通过靶向miR-940/BMPER轴抑制非小细胞肺癌的增殖、迁移、侵袭和糖酵解。
Onco Targets Ther. 2020 Aug 24;13:8427-8439. doi: 10.2147/OTT.S253474. eCollection 2020.
9
Circular RNA hsa_circ_0004396 acts as a sponge of miR-615-5p to promote non-small cell lung cancer progression and radioresistance through the upregulation of P21-Activated Kinase 1.环状 RNA hsa_circ_0004396 通过上调 P21 激活激酶 1 作为 miR-615-5p 的海绵促进非小细胞肺癌的进展和放射抵抗。
J Clin Lab Anal. 2022 Jun;36(6):e24463. doi: 10.1002/jcla.24463. Epub 2022 May 2.
10
Hsa_circ_0046263 Drives the Carcinogenesis and Metastasis of Non-Small Cell Lung Cancer Through the Promotion of NOVA2 by Absorbing Mir-940 as a Molecular Sponge.Hsa_circ_0046263作为分子海绵吸附Mir-940,通过促进NOVA2来驱动非小细胞肺癌的发生和转移。
Cancer Manag Res. 2020 Dec 14;12:12779-12790. doi: 10.2147/CMAR.S272603. eCollection 2020.

引用本文的文献

1
A Multifaceted Giant Protein Microtubule-Actin Cross-Linking Factor 1.一种多面巨型蛋白质微管-肌动蛋白交联因子1
Int J Mol Sci. 2025 Mar 30;26(7):3204. doi: 10.3390/ijms26073204.
2
The role of circular RNAs (circRNAs) as a prognostic factor in lung cancer: a meta-analysis.环状 RNA(circRNAs)作为肺癌预后因素的作用:一项荟萃分析。
BMC Cancer. 2024 Aug 9;24(1):988. doi: 10.1186/s12885-024-12704-w.
3
Advanced approaches of the use of circRNAs as a replacement for cancer therapy.将环状RNA用作癌症治疗替代方法的先进途径。

本文引用的文献

1
Hsa_circ_0070269 inhibits hepatocellular carcinoma progression through modulating miR-182/NPTX1 axis.Hsa_circ_0070269 通过调节 miR-182/NPTX1 轴抑制肝细胞癌进展。
Biomed Pharmacother. 2019 Dec;120:109497. doi: 10.1016/j.biopha.2019.109497. Epub 2019 Oct 10.
2
Tumor-suppressive circular RNAs: Mechanisms underlying their suppression of tumor occurrence and use as therapeutic targets.抑瘤性环状 RNA:其抑制肿瘤发生的作用机制及作为治疗靶点的应用。
Cancer Sci. 2019 Dec;110(12):3630-3638. doi: 10.1111/cas.14211. Epub 2019 Oct 25.
3
The circ_0021977/miR-10b-5p/P21 and P53 regulatory axis suppresses proliferation, migration, and invasion in colorectal cancer.
Noncoding RNA Res. 2024 Mar 30;9(3):811-830. doi: 10.1016/j.ncrna.2024.03.012. eCollection 2024 Sep.
4
Circ_MACF1 targets miR-421 to upregulate FMO2 to suppress paclitaxel resistance and malignant cellular behaviors in lung adenocarcinoma.环状 RNA MACF1 通过靶向 miR-421 上调 FMO2 以抑制肺腺癌中紫杉醇耐药和恶性细胞行为。
Thorac Cancer. 2023 Nov;14(33):3348-3357. doi: 10.1111/1759-7714.15132. Epub 2023 Oct 10.
5
CircRNA-CIRH1A Promotes the Development of Osteosarcoma by Regulating PI3K/AKT and JAK2/STAT3 Signaling Pathways.环状 RNA-CIRH1A 通过调控 PI3K/AKT 和 JAK2/STAT3 信号通路促进骨肉瘤的发展。
Mol Biotechnol. 2024 Sep;66(9):2241-2253. doi: 10.1007/s12033-023-00812-0. Epub 2023 Aug 23.
6
Circular RNAs as biomarkers for lung cancer.环状RNA作为肺癌的生物标志物
Noncoding RNA Res. 2022 Nov 7;8(1):83-88. doi: 10.1016/j.ncrna.2022.11.002. eCollection 2023 Mar.
7
The function and clinical implication of circular RNAs in lung cancer.环状RNA在肺癌中的功能及临床意义
Front Oncol. 2022 Oct 19;12:862602. doi: 10.3389/fonc.2022.862602. eCollection 2022.
8
Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy.FBXW7调控机制及其在免疫治疗中作用的最新见解
Front Oncol. 2022 Jun 24;12:925041. doi: 10.3389/fonc.2022.925041. eCollection 2022.
9
Regulation of apoptosis, autophagy and ferroptosis by non-coding RNAs in metastatic non-small cell lung cancer (Review).非编码RNA对转移性非小细胞肺癌细胞凋亡、自噬和铁死亡的调控(综述)
Exp Ther Med. 2022 May;23(5):352. doi: 10.3892/etm.2022.11279. Epub 2022 Mar 28.
10
CircMYC promotes proliferation, migration, invasion and inhibits apoptosis of small cell lung cancer by targeting miR-145/ Matrix Metallopeptidase 2 axis.CircMYC 通过靶向 miR-145/基质金属蛋白酶 2 轴促进小细胞肺癌的增殖、迁移、侵袭和抑制凋亡。
Bioengineered. 2022 Apr;13(4):10552-10563. doi: 10.1080/21655979.2022.2062978.
环状 RNA circ_0021977/miR-10b-5p/P21 和 P53 调控轴抑制结直肠癌细胞的增殖、迁移和侵袭。
J Cell Physiol. 2020 Mar;235(3):2273-2285. doi: 10.1002/jcp.29135. Epub 2019 Oct 8.
4
Circular RNA SMARCA5 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by miR-19b-3p/HOXA9 axis.环状RNA SMARCA5通过miR-19b-3p/HOXA9轴抑制非小细胞肺癌的增殖、迁移和侵袭。
Onco Targets Ther. 2019 Aug 30;12:7055-7065. doi: 10.2147/OTT.S216320. eCollection 2019.
5
The positive feedback loop FOXO3/CASC11/miR-498 promotes the tumorigenesis of non-small cell lung cancer.FOXO3/CASC11/miR-498 正反馈环路促进非小细胞肺癌的肿瘤发生。
Biochem Biophys Res Commun. 2019 Nov 12;519(3):518-524. doi: 10.1016/j.bbrc.2019.08.136. Epub 2019 Sep 16.
6
Fbxw7 and Skp2 Regulate Stem Cell Switch between Quiescence and Mitotic Division in Lung Adenocarcinoma.Fbxw7 和 Skp2 调控肺腺癌干细胞在静止期和有丝分裂分裂之间的转换。
Biomed Res Int. 2019 Aug 25;2019:9648269. doi: 10.1155/2019/9648269. eCollection 2019.
7
circPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma.环状 RNA 结合蛋白 PTN 通过海绵吸附 miR-145-5p/miR-330-5p 促进胶质瘤的增殖和干性。
J Exp Clin Cancer Res. 2019 Sep 11;38(1):398. doi: 10.1186/s13046-019-1376-8.
8
Hsa_circ_0035483 sponges hsa-miR-335 to promote the gemcitabine-resistance of human renal cancer cells by autophagy regulation.Hsa_circ_0035483 通过自噬调控海绵吸附 hsa-miR-335 促进人肾癌细胞对吉西他滨的耐药性。
Biochem Biophys Res Commun. 2019 Oct 29;519(1):172-178. doi: 10.1016/j.bbrc.2019.08.093. Epub 2019 Sep 3.
9
Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b/c in breast cancer under hypoxia.敲低 circDENND4C 通过上调低氧下乳腺癌中的 miR-200b/c 抑制糖酵解、迁移和侵袭。
J Exp Clin Cancer Res. 2019 Sep 5;38(1):388. doi: 10.1186/s13046-019-1398-2.
10
circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer.环状 RNA KDM4C 通过调控 miR-548p/PBLD 轴抑制乳腺癌进展并减弱阿霉素耐药性。
Oncogene. 2019 Oct;38(42):6850-6866. doi: 10.1038/s41388-019-0926-z. Epub 2019 Aug 12.